Literature DB >> 21730132

Heterodimerization of Mdm2 and Mdm4 is critical for regulating p53 activity during embryogenesis but dispensable for p53 and Mdm2 stability.

Vinod Pant1, Shunbin Xiong, Tomoo Iwakuma, Alfonso Quintás-Cardama, Guillermina Lozano.   

Abstract

Mdm2 and Mdm4 are homologous RING domain-containing proteins that negatively regulate the tumor suppressor p53 under physiological and stress conditions. The RING domain of Mdm2 encodes an E3-ubiquitin ligase that promotes p53 degradation. In addition, Mdm2 and Mdm4 interact through their respective RING domains. The in vivo significance of Mdm2-Mdm4 heterodimerization in regulation of p53 function is unknown. In this study, we generated an Mdm4 conditional allele lacking the RING domain to investigate its role in Mdm2 and p53 regulation. Our results demonstrate that homozygous deletion of the Mdm4 RING domain results in prenatal lethality. Mechanistically, Mdm2-Mdm4 heterodimerization is critical for inhibiting lethal p53 activation during early embryogenesis. However, Mdm2-Mdm4 interaction is dispensable for regulating p53 activity as well as the stability of Mdm2 and p53 at later stages of development. We propose that Mdm4 is a key cofactor of Mdm2 that inhibits p53 activity primarily during early embryogenesis but is dispensable for regulating p53 and Mdm2 stability in the adult mouse.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21730132      PMCID: PMC3141986          DOI: 10.1073/pnas.1102241108

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  MdmX protects p53 from Mdm2-mediated degradation.

Authors:  M W Jackson; S J Berberich
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

2.  A novel MDMX transcript expressed in a variety of transformed cell lines encodes a truncated protein with potent p53 repressive activity.

Authors:  R Rallapalli; G Strachan; B Cho; W E Mercer; D J Hall
Journal:  J Biol Chem       Date:  1999-03-19       Impact factor: 5.157

3.  MDM2 interacts with MDMX through their RING finger domains.

Authors:  S Tanimura; S Ohtsuka; K Mitsui; K Shirouzu; A Yoshimura; M Ohtsubo
Journal:  FEBS Lett       Date:  1999-03-19       Impact factor: 4.124

4.  The phenotype of MDM2 auto-degradation after DNA damage is due to epitope masking by phosphorylation.

Authors:  Qian Cheng; Jiandong Chen
Journal:  Cell Cycle       Date:  2011-04-01       Impact factor: 4.534

5.  Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53.

Authors:  R Honda; H Tanaka; H Yasuda
Journal:  FEBS Lett       Date:  1997-12-22       Impact factor: 4.124

6.  Amplification and overexpression of the MDM4 (MDMX) gene from 1q32 in a subset of malignant gliomas without TP53 mutation or MDM2 amplification.

Authors:  M J Riemenschneider; R Büschges; M Wolter; J Reifenberger; J Boström; J A Kraus; U Schlegel; G Reifenberger
Journal:  Cancer Res       Date:  1999-12-15       Impact factor: 12.701

7.  Significance of HDMX-S (or MDM4) mRNA splice variant overexpression and HDMX gene amplification on primary soft tissue sarcoma prognosis.

Authors:  Frank Bartel; Jördis Schulz; Anja Böhnke; Karen Blümke; Matthias Kappler; Matthias Bache; Hannelore Schmidt; Peter Würl; Helge Taubert; Steffen Hauptmann
Journal:  Int J Cancer       Date:  2005-11-10       Impact factor: 7.396

8.  Rescue of embryonic lethality in Mdm4-null mice by loss of Trp53 suggests a nonoverlapping pathway with MDM2 to regulate p53.

Authors:  J Parant; A Chavez-Reyes; N A Little; W Yan; V Reinke; A G Jochemsen; G Lozano
Journal:  Nat Genet       Date:  2001-09       Impact factor: 38.330

9.  Mdm2 promotes the rapid degradation of p53.

Authors:  Y Haupt; R Maya; A Kazaz; M Oren
Journal:  Nature       Date:  1997-05-15       Impact factor: 49.962

10.  Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome.

Authors:  Gene A Lang; Tomoo Iwakuma; Young-Ah Suh; Geng Liu; V Ashutosh Rao; John M Parant; Yasmine A Valentin-Vega; Tamara Terzian; Lisa C Caldwell; Louise C Strong; Adel K El-Naggar; Guillermina Lozano
Journal:  Cell       Date:  2004-12-17       Impact factor: 41.582

View more
  85 in total

1.  MdmX is required for p53 interaction with and full induction of the Mdm2 promoter after cellular stress.

Authors:  Lynn Biderman; Masha V Poyurovsky; Yael Assia; James L Manley; Carol Prives
Journal:  Mol Cell Biol       Date:  2012-01-30       Impact factor: 4.272

2.  Pla2g16 phospholipase mediates gain-of-function activities of mutant p53.

Authors:  Shunbin Xiong; Huolin Tu; Madhusudhan Kollareddy; Vinod Pant; Qin Li; Yun Zhang; James G Jackson; Young-Ah Suh; Ana C Elizondo-Fraire; Peirong Yang; Gilda Chau; Mehrnoosh Tashakori; Amanda R Wasylishen; Zhenlin Ju; Hilla Solomon; Varda Rotter; Bin Liu; Adel K El-Naggar; Lawrence A Donehower; Luis Alfonso Martinez; Guillermina Lozano
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-14       Impact factor: 11.205

3.  Aberrant activation of p53 due to loss of MDM2 or MDMX causes early lens dysmorphogenesis.

Authors:  Yiwei Zhang; Xin Zhang; Hua Lu
Journal:  Dev Biol       Date:  2014-09-28       Impact factor: 3.582

4.  MOZ increases p53 acetylation and premature senescence through its complex formation with PML.

Authors:  Susumu Rokudai; Oleg Laptenko; Suzzette M Arnal; Yoichi Taya; Issay Kitabayashi; Carol Prives
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-19       Impact factor: 11.205

5.  The MDM2 RING domain and central acidic domain play distinct roles in MDM2 protein homodimerization and MDM2-MDMX protein heterodimerization.

Authors:  Patrick L Leslie; Hengming Ke; Yanping Zhang
Journal:  J Biol Chem       Date:  2015-03-25       Impact factor: 5.157

6.  Mdm2 Splice isoforms regulate the p53/Mdm2/Mdm4 regulatory circuit via RING domain-mediated ubiquitination of p53 and Mdm4.

Authors:  Chuandong Fan; Xinjiang Wang
Journal:  Cell Cycle       Date:  2017-02-06       Impact factor: 4.534

Review 7.  Negative auto-regulators trap p53 in their web.

Authors:  Xiang Zhou; Bo Cao; Hua Lu
Journal:  J Mol Cell Biol       Date:  2017-02-01       Impact factor: 6.216

8.  AXL receptor signalling suppresses p53 in melanoma through stabilization of the MDMX-MDM2 complex.

Authors:  Anna de Polo; Zhongling Luo; Casimiro Gerarduzzi; Xiang Chen; John B Little; Zhi-Min Yuan
Journal:  J Mol Cell Biol       Date:  2017-04-01       Impact factor: 6.216

9.  Interrogation of MDM2 phosphorylation in p53 activation using native chemical ligation: the functional role of Ser17 phosphorylation in MDM2 reexamined.

Authors:  Changyou Zhan; Kristen Varney; Weirong Yuan; Le Zhao; Wuyuan Lu
Journal:  J Am Chem Soc       Date:  2012-04-04       Impact factor: 15.419

10.  Mdm2 Phosphorylation Regulates Its Stability and Has Contrasting Effects on Oncogene and Radiation-Induced Tumorigenesis.

Authors:  Michael I Carr; Justine E Roderick; Hugh S Gannon; Michelle A Kelliher; Stephen N Jones
Journal:  Cell Rep       Date:  2016-08-25       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.